Jump to ContentJump to Main Navigation
FDA in the Twenty-First CenturyThe Challenges of Regulating Drugs and New Technologies$
Users without a subscription are not able to see the full content.

Holly Fernandez Lynch and I. Glenn Cohen

Print publication date: 2015

Print ISBN-13: 9780231171182

Published to Columbia Scholarship Online: May 2016

DOI: 10.7312/columbia/9780231171182.001.0001

Show Summary Details
Page of

PRINTED FROM COLUMBIA SCHOLARSHIP ONLINE (www.columbia.universitypressscholarship.com). (c) Copyright University of Minnesota Press, 2021. All Rights Reserved. An individual user may print out a PDF of a single chapter of a monograph in CUPSO for personal use.date: 05 August 2021

Innovation Policy Failures in the Manufacturing of Drugs

Innovation Policy Failures in the Manufacturing of Drugs

Chapter:
(p.343) Chapter Eighteen Innovation Policy Failures in the Manufacturing of Drugs
Source:
FDA in the Twenty-First Century
Author(s):

W. Nicholson Price

Publisher:
Columbia University Press
DOI:10.7312/columbia/9780231171182.003.0024

Drug manufacturing today is both high cost and poor quality, due largely to stagnant technological development. Improving innovation incentives and decreasing regulatory hurdles could lead to significant positive change.

Keywords:   drug manufacturing, innovation, industrial design, regulated industries, FDA, pharmaceuticals

Columbia Scholarship Online requires a subscription or purchase to access the full text of books within the service. Public users can however freely search the site and view the abstracts and keywords for each book and chapter.

Please, subscribe or login to access full text content.

If you think you should have access to this title, please contact your librarian.

To troubleshoot, please check our FAQs, and if you can't find the answer there, please contact us .